Susquehanna International Group’s ProPhase Labs PRPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,660
Closed -$160K 13101
2023
Q3
$160K Sell
3,660
-2,620
-42% -$153K ﹤0.01% 10479
2023
Q2
$456K Buy
6,280
+4,180
+199% +$340K ﹤0.01% 8536
2023
Q1
$160K Buy
2,100
+110
+6% +$8.87K ﹤0.01% 10851
2022
Q4
$192K Sell
1,990
-190
-9% -$20.5K ﹤0.01% 10189
2022
Q3
$246K Buy
2,180
+950
+77% +$111K ﹤0.01% 10305
2022
Q2
$156K Sell
1,230
-1,720
-58% -$151K ﹤0.01% 10977
2022
Q1
$207K Buy
2,950
+1,150
+64% +$80K ﹤0.01% 11162
2021
Q4
$129K Sell
1,800
-3,970
-69% -$247K ﹤0.01% 11960
2021
Q3
$300K Sell
5,770
-980
-15% -$58.4K ﹤0.01% 10599
2021
Q2
$419K Buy
6,750
+1,290
+24% +$72.5K ﹤0.01% 10008
2021
Q1
$404K Buy
+5,460
New +$524K ﹤0.01% 9965

Other funds holding PRPH

Susquehanna International Group's PRPH Position: Q4 2025 in Review

Susquehanna International Group sold out of ProPhase Labs (PRPH) in Q4 2025, closing a stake of 39,791 shares — an estimated $182K sold.

Susquehanna International Group first reported a position in PRPH in Q3 2018 and held it in 20 quarters. The position peaked at $446K in Q4 2022. 17 funds tracked by Wall St. Rank hold PRPH as of Q4 2025.

  • Susquehanna International Group reported no remaining ProPhase Labs position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 39,791 ProPhase Labs shares in Q4 2025, an estimated $182K.
  • Susquehanna International Group first reported a position in ProPhase Labs in Q3 2018 and held it in 20 quarters.
  • Susquehanna International Group's ProPhase Labs position peaked at $446K in Q4 2022.
  • 17 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.